CERS
Price
$1.56
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
342.62M
26 days until earnings call
SAFLY
Price
$2.29
Change
+$0.06 (+2.69%)
Updated
Jul 1 closing price
Capitalization
529.04M
Interact to see
Advertisement

CERS vs SAFLY

Header iconCERS vs SAFLY Comparison
Open Charts CERS vs SAFLYBanner chart's image
Cerus
Price$1.56
Change-$0.00 (-0.00%)
Volume$1.22K
Capitalization342.62M
Safilo Group Spa
Price$2.29
Change+$0.06 (+2.69%)
Volume$100
Capitalization529.04M
CERS vs SAFLY Comparison Chart in %
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. SAFLY commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Buy and SAFLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (CERS: $1.56 vs. SAFLY: $2.29)
Brand notoriety: CERS and SAFLY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 0% vs. SAFLY: 26%
Market capitalization -- CERS: $342.62M vs. SAFLY: $529.04M
CERS [@Medical Specialties] is valued at $342.62M. SAFLY’s [@Medical Specialties] market capitalization is $529.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileSAFLY’s FA Score has 0 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • SAFLY’s FA Score: 0 green, 5 red.
According to our system of comparison, CERS is a better buy in the long-term than SAFLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 5 TA indicator(s) are bullish while SAFLY’s TA Score has 0 bullish TA indicator(s).

  • CERS’s TA Score: 5 bullish, 4 bearish.
  • SAFLY’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, CERS is a better buy in the short-term than SAFLY.

Price Growth

CERS (@Medical Specialties) experienced а +14.71% price change this week, while SAFLY (@Medical Specialties) price change was +2.69% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

CERS is expected to report earnings on Jul 31, 2025.

SAFLY is expected to report earnings on Apr 03, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAFLY($529M) has a higher market cap than CERS($343M). SAFLY YTD gains are higher at: 2.691 vs. CERS (1.299). SAFLY has higher annual earnings (EBITDA): 127M vs. CERS (-26.34M). SAFLY has more cash in the bank: 78.7M vs. CERS (65.9M). CERS has less debt than SAFLY: CERS (96M) vs SAFLY (184M). SAFLY has higher revenues than CERS: SAFLY (1.03B) vs CERS (156M).
CERSSAFLYCERS / SAFLY
Capitalization343M529M65%
EBITDA-26.34M127M-21%
Gain YTD1.2992.69148%
P/E RatioN/A9.32-
Revenue156M1.03B15%
Total Cash65.9M78.7M84%
Total Debt96M184M52%
FUNDAMENTALS RATINGS
CERS vs SAFLY: Fundamental Ratings
CERS
SAFLY
OUTLOOK RATING
1..100
3850
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
10092
SMR RATING
1..100
9690
PRICE GROWTH RATING
1..100
5257
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (45) in the Medical Specialties industry is in the same range as SAFLY (66) in the null industry. This means that CERS’s stock grew similarly to SAFLY’s over the last 12 months.

SAFLY's Profit vs Risk Rating (92) in the null industry is in the same range as CERS (100) in the Medical Specialties industry. This means that SAFLY’s stock grew similarly to CERS’s over the last 12 months.

SAFLY's SMR Rating (90) in the null industry is in the same range as CERS (96) in the Medical Specialties industry. This means that SAFLY’s stock grew similarly to CERS’s over the last 12 months.

CERS's Price Growth Rating (52) in the Medical Specialties industry is in the same range as SAFLY (57) in the null industry. This means that CERS’s stock grew similarly to SAFLY’s over the last 12 months.

CERS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as SAFLY (100) in the null industry. This means that CERS’s stock grew similarly to SAFLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSSAFLY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
17%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
25%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
12%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
12%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 22 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YAMCY7.050.08
+1.08%
Yamaha Corp.
REMRF0.30N/A
+0.60%
ATLAS SALT INC.
DKILY12.190.02
+0.16%
Daikin Industries Ltd.
GTHP0.27N/A
N/A
Guided Therapeutics, Inc.
SZGPY2.37N/A
N/A
Salzgitter AG

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with LAB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
N/A
LAB - CERS
53%
Loosely correlated
-1.46%
NNOX - CERS
47%
Loosely correlated
-0.19%
SGHT - CERS
46%
Loosely correlated
+1.20%
UTMD - CERS
46%
Loosely correlated
+1.66%
DHR - CERS
45%
Loosely correlated
+0.35%
More

SAFLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAFLY has been loosely correlated with BIOQ. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SAFLY jumps, then BIOQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLY
1D Price
Change %
SAFLY100%
N/A
BIOQ - SAFLY
34%
Loosely correlated
N/A
CNVVF - SAFLY
32%
Poorly correlated
N/A
TCHBF - SAFLY
29%
Poorly correlated
N/A
LZAGY - SAFLY
28%
Poorly correlated
-0.20%
CERS - SAFLY
25%
Poorly correlated
N/A
More